Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group

PURPOSE: To investigate whether event-free survival (EFS) can be maintained among children and adolescents with intermediate-risk (IR) malignant germ cell tumors (MGCT) if the administration of cisplatin, etoposide, and bleomycin (PEb) is reduced from four to three cycles and compressed from 5 to 3...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Shaikh, Furqan, Cullen, John W., Olson, Thomas A., Pashankar, Farzana, Malogolowkin, Marcio H., Amatruda, James F., Villaluna, Doojduen, Krailo, Mark, Billmire, Deborah F., Rescorla, Frederick J., Egler, Rachel A., Dicken, Bryan J., Ross, Jonathan H., Schlatter, Marc, Rodriguez-Galindo, Carlos, Frazier, A. Lindsay
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455599/
https://ncbi.nlm.nih.gov/pubmed/28240974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.6544
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares